EKA SPRL
Dissolution judiciaire ou nullitéThe score of EKA shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2016
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
EKA's annual accounts
| 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|
| Net result | −1,475 € | ||||
| Equity | 156,794 € | ||||
| Cash | 10,869 € | ||||
| EBITDA | −4,992 € | ||||
| Total assets | 157,490 € |
Filed annual accounts
- Year ended 31 Dec 2016filed on 26 Jul 2017
- Year ended 31 Dec 2015filed on 01 Jul 2016
- Year ended 31 Dec 2014filed on 19 Jun 2015
- Year ended 31 Dec 2013filed on 29 Jul 2014
- Year ended 31 Dec 2012filed on 01 Jul 2013
EKA's financial analysis
- Solvency99.6%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of EKA
EKA's publications in the Belgian Gazette
No Belgian Gazette publication known for this company.
Company number, VAT number and registered office
- Company number (CBE)
- 0419.541.232
- VAT number
- BE0419541232
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 02 Jul 1979
- Registered office
- 2980 Zoersel
- Latest accounts
- 2016 · filed on 26 Jul 2017
- Activity
- Manufacture of basic pharmaceutical products (NACE 2110001)
EKA (SPRL) has been based in Zoersel since 1979, active in: manufacture of basic pharmaceutical products. For 2016, it reports a net loss of 1,475 € and equity of 156,794 €; its revenue is not published. Its solvency stands at 99.6%, above the median of its sector (56.0%).
Companies similar to EKA
Same activity (NACE code), registered office in the same province, closest balance-sheet size.
- Yaro Preclinical Consulting Manufacture of basic pharmaceutical products Turnhout · balance sheet 158,481 €
- CO-Ordinating Multi Media IN Productions Manufacture of basic pharmaceutical products Antwerp · balance sheet 160,559 €
- Marietta, Technisch Adviesbureau Manufacture of basic pharmaceutical products Essen · balance sheet 163,110 €
- Abella Mar Manufacture of basic pharmaceutical products Kapellen · balance sheet 150,376 €
- Moose Engineering & Equipment Manufacture of basic pharmaceutical products Antwerp · balance sheet 148,745 €
- Novozymatic Manufacture of basic pharmaceutical products Kapellen · balance sheet 148,440 €
- MC Group Manufacture of basic pharmaceutical products Oud-Turnhout · balance sheet 171,393 €
- Xonar Manufacture of basic pharmaceutical products Putte · balance sheet 143,913 €
Frequently asked questions about EKA
What is the revenue of EKA?
EKA files its accounts in a format where revenue is optional: it is not published for 2016.
What is the VAT number of EKA?
In Belgium, the VAT number is the company number prefixed with BE: BE0419541232 for EKA, if the company is VAT-registered. Its company number (CBE) is 0419.541.232.
Where is the registered office of EKA?
According to the CBE register, the registered office of EKA is in 2980 Zoersel.
What is the equity of EKA?
At the close of the 2016 financial year, the equity of EKA amounts to 156,794 €, a solvency of 99.6% of total assets.
Who manages EKA?
The register lists 1 active mandates at EKA. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of EKA
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →